Back to Market返回行情

TTRX Turn Therapeutics Inc.

USHealthcare
$9.44+7.15%ClosedMarket Cap: $281.2M

As of 2026-07-10 16:00

Why TTRX matters now

Turn Therapeutics Inc. (TTRX) is a US stock in Healthcare. The latest InvestLog snapshot shows $9.44 with +7.15% on the session and $281.2M in market capitalization; recent performance reads 1-month +29.01% and YTD +48.98%.

The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $-971.0K, and EPS of $-0.03. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -2.2%.

The latest indexable market news headline is "Why Is Turn Therapeutics Stock Trading Higher Today?" from Benzinga.

Additional event context on this page matters because analyst consensus is Buy with a median target of $—. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

28.28

P/S

0.00

EV/EBITDA

-44.71

DCF Value

$0.18

FCF Yield

-2.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-116.8%

ROA

-20.6%

ROIC

-49.6%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$0.00$-971.0K$-0.03
Q4 2025$0.00$279.1K$0.01
FY 2025$0.00$-3.2M$-0.23
Q3 2025$0.00$-1.9M$-0.07

Analyst Ratings

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
D. Boral CapitalBuy
2026-03-24
D. Boral CapitalBuy
2026-01-20

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

2.77

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.